loading

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31
Periodenlänge 3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
$92.85
price down icon 0.11%
$122.99
price down icon 3.23%
$34.52
price up icon 5.02%
$59.02
price down icon 0.27%
$205.48
price down icon 28.31%
ONC ONC
$322.08
price down icon 1.57%
Kapitalisierung:     |  Volumen (24h):